KALYDECO 75 mg, granules in a sachet 28 sachets
Active ingredients: Ivacaftor
Commercialized according to BDPMDispensing in France: Prescription only
Granules28 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KALYDECO 75 mg, granulés en sachet
- Pharmaceutical form
- granulés
- Route of administration
- orale
- Presentation description
- 28 (4 x 7) sachets BoPET : polyéthylène téréphtalate biaxialement orienté polyéthylène aluminium (conditionnement multiple)
- Marketing authorisation holder
- VERTEX PHARMACEUTICALS (IRELAND)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Feb 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68381052CIP73028075CIP133400930280751Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IVACAFTORgranulés | 75 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.